Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-14-007803
Filing Date
2014-05-02
Accepted
2014-05-02 09:47:38
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q govx20140331_10q.htm 10-Q 409430
2 EXHIBIT 31.1 ex31-1.htm EX-31 15658
3 EXHIBIT 31.2 ex31-2.htm EX-31 15557
4 EXHIBIT 32.1 ex32-1.htm EX-32 4918
5 EXHIBIT 32.2 ex32-2.htm EX-32 5535
  Complete submission text file 0001437749-14-007803.txt   2058326

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS govx-20140331.xml EX-101.INS 193815
7 EXHIBIT 101.SCH govx-20140331.xsd EX-101.SCH 23403
8 EXHIBIT 101.CAL govx-20140331_cal.xml EX-101.CAL 19969
9 EXHIBIT 101.DEF govx-20140331_def.xml EX-101.DEF 99691
10 EXHIBIT 101.LAB govx-20140331_lab.xml EX-101.LAB 162670
11 EXHIBIT 101.PRE govx-20140331_pre.xml EX-101.PRE 102223
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52091 | Film No.: 14807198
SIC: 8731 Services-Commercial Physical & Biological Research